Premier Alternatives

SimBioSys

Chicago, IL · Founded 2017 · Privately Held (backing)

Developer of a medical platform intended to deploy computational oncology to transform decision-making and patient experience in cancer care. SimBioSys is based in Chicago, IL and was founded in 2017. Its last reported valuation was $39 million in Jul 2021. It has raised $21.1 million across 2 recorded rounds; the latest was a $5.2 million early-stage round in Dec 2024.

Last reported valuation
$39.0M
Oct 2026
Priced at
—
Total raised
$21.1M
Last round
Early Stage VC
Dec 2024

SimBioSys key facts

as of Oct 2026
  • Developer of a medical platform intended to deploy computational oncology to transform decision-making and patient experience in cancer care.
  • SimBioSys is valued at approximately $39.0M as of Oct 2026 (last reported valuation).
  • It has raised $21.1M across 2 recorded rounds; the latest was Early Stage VC ($5.2M) in Dec 2024.
  • Notable investors include Mayo Clinic, Fox Ventures, Genoa Ventures, AV8 Ventures, Calculus Venture Capital — 11 tracked in total.
  • SimBioSys has filed 2 Form Ds with the SEC since 2018, most recently Jan 2025 ($5.2M sold to 13 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$39.0M

SimBioSys's last reported valuation, Jul 2021. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of SimBioSys with a free account
  • ·The complete investor list: 11 names
  • ·Watch SimBioSys: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

SimBioSys funding rounds

2 rounds
Dec 2024Early Stage VC$5.2MSEC filing▮
Nov 2018Debt$900KSEC filing▮
Full funding history →

SimBioSys valuation

SimBioSys's last reported valuation was $39 million in Jul 2021. No priced round, secondary trade or fund mark has surfaced since.

How much has SimBioSys raised?

SimBioSys has raised $21.1 million in total; 2 of its rounds are on record. The largest on record was a $900,000 debt round in Nov 2018; the most recent was a $5.2 million early-stage round in Dec 2024.

SimBioSys has filed 2 Form Ds with the SEC since 2018, most recently in Jan 2025 ($5.2 million sold to 13 investors).

SimBioSys investors

11 investors are on record for SimBioSys, including Mayo Clinic, Fox Ventures, Genoa Ventures and AV8 Ventures. The early-stage round in Dec 2024 drew 13 investors.

About SimBioSys

Developer of a medical platform intended to deploy computational oncology to transform decision-making and patient experience in cancer care. The company's offerings include comprehensive datasets collected during diagnosis into personalized virtual tumors through computational scenario analysis, enabling doctors to provide a better understanding of the disease and get treated accordingly.

Sector
Healthcare
HQ
Chicago, IL, United States
Founded
2017
Employees
30
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.